Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001512455 | SCV001719879 | benign | Cystic fibrosis | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001512455 | SCV002685502 | benign | Cystic fibrosis | 2017-04-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002490598 | SCV002800079 | likely benign | Bronchiectasis with or without elevated sweat chloride 1; Cystic fibrosis; Hereditary pancreatitis; Congenital bilateral aplasia of vas deferens from CFTR mutation | 2021-12-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826605 | SCV002080049 | benign | CFTR-related disorder | 2020-01-05 | no assertion criteria provided | clinical testing |